retatrutide safety profile clinical trials The power of three: Retatrutide's role in modern obesity and diabetes therapy Substack Series 3 of 6:

In clinical trials, people who took semaglutide lost an average of 15 to 20% of their body weight over the course of one year, which is a remarkable result

The relationship between tirzepatide and menstrual irregularities is primarily indirect, mediated through significant weight loss and metabolic improvements

[Confidence: High]

Those numbers were unprecedented at the time of publication and immediately positioned Retatrutide as the most potent obesity treatment ever studied in a clinical setting

And theyre stacking them in different formulations, its like a mistrust of the authorities, but a belief in unproven technologies in a way that I find culturally very interesting

Diets high in processed foods, added sugars, and unhealthy fats may contribute to weight gain and metabolic issues, which can indirectly affect testosterone levels